Applications Published 27 February 2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Balsam for the treatment of surface burns and chafing rashes
Kyrn 1181029*
Tanacetum parthenium extract
Indena 1181030*
Novel antiangiogenic peptides
Children's Medical Center 1181031*
Use of a pharmacological agent in the diagnosis of obsessive-compulsive disorder
Laekartjaenster/Vaestsverige 1181033*
Combination of immunosuppressive agents for the treatment or prevention of graft rejections
Novartis 1181034*
Substantially oil-free cyclosporin compsns
Novartis 1181035*
Pharmaceutical compsns of erythropoietin
Ortho-McNeil Pharmaceutical 1181036*
Asthma-associated factors as targets for treating atopic allergies, including asthma and related disorders
Genaera Corp 1181037*
Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
Thiel, Steffen; Jensenius, Jens Christian 1181038*
Therapeutic uses of BPI protein in humans with otitis media with effusion
Xoma 1181039*
Compsns of a-beta peptide and processes for producing same
Neuralab 1181040*
Morphogen-induced enhancement of fertility
Curis 1181041*
Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
Licenta 1181042*
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
Amylin Pharmaceuticals 1181043*
Immobilised lactoferrin (I IM/I-LF) antimicrobial agents and uses thereof
Naidu, Satyanarayan 1181044*
Use of asparaginase and glutaminase to treat autoimmune disease and graft versus host disease
Children's Hospital of Los Angeles 1181045*
10-formyltetrahydrofolate dehydrogenase as therapeutic agent
Pharmaproducts 1181046*
Compsn comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
VSL Pharma 1181047*
A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor
AstraZeneca 1181048*
Cardioprotective compsn comprising ceruloplasmin and uses thereof
Gestilab 1181049*